Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNGL
4601
DELISTED
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
| $3.11M | ﹤0.01% |
310,931
-1,126
| -0.4% | -$11.3K |
|
4602
Invesco Leisure and Entertainment ETF
PEJ
$314M
| $3.1M | ﹤0.01% |
85,513
+71,983
| +532% | +$3M |
|
|
LOGC
4603
CALL
DELISTED
ContextLogic
LOGC
| $3.1M | ﹤0.01% |
64,623
+7,936
| +14% | +$430K |
|
4604
Global X Uranium ETF
URA
$6.27B
| $3.1M | ﹤0.01% |
167,097
-125,647
| -43% | -$2.83M |
|
|
DOC
4605
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $3.1M | ﹤0.01% |
177,667
-130,644
| -42% | -$2.31M |
|
4606
TriCo Bancshares
TCBK
$1.84B
| $3.1M | ﹤0.01% |
67,909
-12,766
| -16% | -$538K |
|
|
MREO
4607
Mereo BioPharma
MREO
$50.9M
| $3.1M | ﹤0.01% |
2,763,425
-1,142,910
| -29% | -$886K |
|
4608
PUT
Darling Ingredients
DAR
$10.6B
| $3.09M | ﹤0.01% |
51,700
-50,000
| -49% | -$3.8M |
|
4609
Freedom 100 Emerging Markets ETF
FRDM
$3.43B
| $3.09M | ﹤0.01% |
+112,198
| New | +$3.46M |
|
4610
Golub Capital BDC
GBDC
$3.44B
| $3.09M | ﹤0.01% |
238,439
-415,556
| -64% | -$5.95M |
|
4611
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
| $3.09M | ﹤0.01% |
59,093
+26,236
| +80% | +$1.4M |
|
|
TUP
4612
DELISTED
Tupperware Brands Corporation
TUP
| $3.09M | ﹤0.01% |
487,343
+329,429
| +209% | +$3.68M |
|
|
NARI
4613
CALL
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.09M | ﹤0.01% |
45,400
+8,700
| +24% | +$625K |
|
4614
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.56B
| $3.08M | ﹤0.01% |
+88,655
| New | +$3.38M |
|
4615
PUT
Valaris
VAL
$5.95B
| $3.08M | ﹤0.01% |
73,000
+14,300
| +24% | +$770K |
|
4616
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$744M
| $3.08M | ﹤0.01% |
147,536
+46,179
| +46% | +$1.03M |
|
4617
CALL
iShares Core MSCI Emerging Markets ETF
IEMG
$159B
| $3.08M | ﹤0.01% |
62,800
+36,800
| +142% | +$1.9M |
|
4618
PUT
First Horizon
FHN
$12.4B
| $3.08M | ﹤0.01% |
140,900
-74,500
| -35% | -$1.67M |
|
4619
PUT
Frontline
FRO
$9.17B
| $3.08M | ﹤0.01% |
347,600
-300
| -0.1% | -$2.71K |
|
4620
CALL
Black Stone Minerals
BSM
$3.05B
| $3.08M | ﹤0.01% |
224,900
+146,300
| +186% | +$2.22M |
|
4621
VanEck Agribusiness ETF
MOO
$976M
| $3.08M | ﹤0.01% |
35,555
-691
| -2% | -$67.4K |
|
4622
Silgan Holdings
SLGN
$4.49B
| $3.07M | ﹤0.01% |
74,336
+42,971
| +137% | +$1.89M |
|
|
MOMO
4623
CALL
Hello Group
MOMO
$850M
| $3.07M | ﹤0.01% |
608,400
+376,200
| +162% | +$1.97M |
|
4624
MSCI
MSCI
$41.4B
| $3.07M | ﹤0.01% |
7,452
-141,573
| -95% | -$61.6M |
|
4625
Nuveen ESG US Aggregate Bond ETF
NUBD
$464M
| $3.07M | ﹤0.01% |
134,284
+115,537
| +616% | +$2.67M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.